Wound Bacterial Microbiota and Their Antibiotic Resistance

Wounds and Injuries Clinical Trial

Official title:

Wound Bacterial Microbiota and Their Antibiotic Resistance: a Prospective Cohort Study of Hospitalized Patients Originating From the Syrian Armed Conflict

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02744144
• Other study ID #: KISOS002
• Status: Completed
• Phase: N/A
• First received: April 13, 2016
• Last updated: May 31, 2017
• Start date: September 2014
• Est. completion date: June 2016

Study information

• Verified date: May 2017
• Source: Karolinska Institutet
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The purpose of the study is to explore the microbiology in war-associated wounds of hospitalized patients from the Syrian armed conflict. Cultures collected from acute wounds with clinical signs of infection will be analyzed.

Description:

War-associated injuries often result in soft tissue and bone being contaminated with foreign material, leading to infection (Fares et al. 2013; Covey, Lurate, and Hatton 2000). Wound infections remain the greatest risk to life and restoration of function in war-wounded that survive the first few hours (Tong 1972; Murray 2008).

The Syrian armed conflict broke out in 2011 and quickly deteriorated. Médecins Sans Frontières/Doctors Without Borders (MSF) runs an emergency trauma project in the Ministry of Health hospital in Ar Ramtha, Jordan, less than five kilometers from the Syrian border. At this facility patients from the Syrian armed conflict receive treatment for blast- and gunshot-injuries. Wounds are treated according to the International Committee of the Red Cross war surgery protocol (Giannou and Baldan 2010). Wound management and healing has been difficult and time consuming, often complicated by infections and antibiotic resistance.

Recommendations for treatment of war-associated infections are generally not supported by cohort studies (Murray et al. 2008). High rates of war wound infections caused by antimicrobial drug resistant organisms have been shown in the Middle East but reports generally only include combatants. Due to the use of body armor and forward medical therapy this data may not be applicable to a civilian setting. Furthermore, available studies are either performed on old wounds (Teicher et al. 2014) or on all available culture samples, disregarding infection signs (Sutter et al. 2011; Dau, Tloba, and Daw 2013). Without clinical signs of infection, routine collection of peri-debridement culture samples is inappropriate in war-associated injuries (Murray et al. 2008). The differentiation between contamination and infecting organisms is crucial in order to avoid unnecessary medication, especially limit the use of broad-spectrum antibiotics as overuse may lead to development of multi-drug resistant organisms (Eardley et al. 2011). Cultures collected from acute wounds with clinical signs of infection will be analyzed.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 457
• Est. completion date: June 2016
• Est. primary completion date: June 2016
• Accepts healthy volunteers: No
• Gender: All
• Age group: N/A and older

Eligibility

Inclusion Criteria:

• Patients that receive surgical treatment for war-associated injuries, irrespective of injury location, injury mechanism, time from injury and prior treatment

• Patients that receive treatment during the study period and are later re-admitted will only be counted as one patient

Exclusion Criteria:

• Patients that are only re-admitted during the study period, i.e. patients that received primary treatment by MSF before study initiation

Related Conditions & MeSH terms

• Arm Injuries
• Leg Injuries
• Soft Tissue Injuries
• War-Related Injuries
• Wound Infection
• Wounds and Injuries
• Wounds, Gunshot
• Wounds, Penetrating

Locations

Country	Name	City	State
Jordan	Ministry of Health hospital	Ar Ramtha	Irbid

Sponsors (2)

Lead Sponsor	Collaborator
Karolinska Institutet	Medecins Sans Frontieres, Netherlands

Country where clinical trial is conducted

Jordan, 

References & Publications (10)

Covey DC, Lurate RB, Hatton CT. Field hospital treatment of blast wounds of the musculoskeletal system during the Yugoslav civil war. J Orthop Trauma. 2000 May;14(4):278-86; discussion 277. — View Citation

Dau AA, Tloba S, Daw MA. Characterization of wound infections among patients injured during the 2011 Libyan conflict. East Mediterr Health J. 2013 Apr;19(4):356-61. — View Citation

Eardley WG, Brown KV, Bonner TJ, Green AD, Clasper JC. Infection in conflict wounded. Philos Trans R Soc Lond B Biol Sci. 2011 Jan 27;366(1562):204-18. doi: 10.1098/rstb.2010.0225. Review. — View Citation

Fares Y, El-Zaatari M, Fares J, Bedrosian N, Yared N. Trauma-related infections due to cluster munitions. J Infect Public Health. 2013 Dec;6(6):482-6. doi: 10.1016/j.jiph.2013.05.006. Epub 2013 Jul 31. — View Citation

Giannou C, Baldan M. War Surgery: Working With Limited Resources in Armed Conflict and Other Situations of Violence. ICRC; 2010.

Murray CK, Hsu JR, Solomkin JS, Keeling JJ, Andersen RC, Ficke JR, Calhoun JH. Prevention and management of infections associated with combat-related extremity injuries. J Trauma. 2008 Mar;64(3 Suppl):S239-51. doi: 10.1097/TA.0b013e318163cd14. Review. — View Citation

Murray CK. Infectious disease complications of combat-related injuries. Crit Care Med. 2008 Jul;36(7 Suppl):S358-64. doi: 10.1097/CCM.0b013e31817e2ffc. Review. — View Citation

Sutter DE, Bradshaw LU, Simkins LH, Summers AM, Atha M, Elwood RL, Robertson JL, Murray CK, Wortmann GW, Hospenthal DR. High incidence of multidrug-resistant gram-negative bacteria recovered from Afghan patients at a deployed US military hospital. Infect Control Hosp Epidemiol. 2011 Sep;32(9):854-60. doi: 10.1086/661284. — View Citation

Teicher CL, Ronat JB, Fakhri RM, Basel M, Labar AS, Herard P, Murphy RA. Antimicrobial drug-resistant bacteria isolated from Syrian war-injured patients, August 2011-March 2013. Emerg Infect Dis. 2014 Nov;20(11):1949-51. doi: 10.3201/eid2011.140835. — View Citation

Tong MJ. Septic complications of war wounds. JAMA. 1972 Feb 21;219(8):1044-7. — View Citation

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Proportion of patients that develops infections after receiving surgical treatment		30 days
Secondary	Frequency of different bacterial microbiota in wounds with clinical signs of infection	For wounds with clinical signs of infection the bacterial microbiota will be characterized.	30 days
Secondary	Frequency of microbiota with antibiotic resistance in wounds with clinical signs of infection	For wounds with clinical signs of infection the the antibiotic resistance patterns of the bacterial microbiota will be characterized.	30 days
Secondary	Length of stay	Length of hospital stay	30 days
Secondary	Surgery	Number and type of surgeries	30 days
Secondary	Death	Mortality	30 days